BNP Paribas Financial Markets’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-5,196
| Closed | -$26.8K | – | 3932 |
|
|
2019
Q2 | $26.8K | Sell |
5,196
-4,471
| -46% | -$23.1K | ﹤0.01% | 3164 |
|
|
2019
Q1 | $34.8K | Buy |
9,667
+9,652
| +64,347% | +$34.7K | ﹤0.01% | 3115 |
|
|
2018
Q4 | $92 | Sell |
15
-1,402
| -99% | -$8.6K | ﹤0.01% | 3515 |
|
|
2018
Q3 | $8.28K | Sell |
1,417
-111
| -7% | -$648 | ﹤0.01% | 3155 |
|
|
2018
Q2 | $6.49K | Sell |
1,528
-7,455
| -83% | -$31.7K | ﹤0.01% | 3324 |
|
|
2018
Q1 | $39.6K | Buy |
8,983
+186
| +2% | +$820 | ﹤0.01% | 3091 |
|
|
2017
Q4 | $46.3K | Buy |
8,797
+5,252
| +148% | +$27.6K | ﹤0.01% | 3043 |
|
|
2017
Q3 | $21.7K | Buy |
3,545
+244
| +7% | +$1.5K | ﹤0.01% | 3038 |
|
|
2017
Q2 | $23.9K | Buy |
3,301
+3,255
| +7,076% | +$23.5K | ﹤0.01% | 3042 |
|
|
2017
Q1 | $244 | Sell |
46
-1,737
| -97% | -$9.21K | ﹤0.01% | 3349 |
|
|
2016
Q4 | $12.8K | Sell |
1,783
-688
| -28% | -$4.94K | ﹤0.01% | 2815 |
|
|
2016
Q3 | $23.1K | Buy |
2,471
+1,161
| +89% | +$10.9K | ﹤0.01% | 2803 |
|
|
2016
Q2 | $8.28K | Buy |
+1,310
| New | +$8.28K | ﹤0.01% | 3000 |
|
|
2016
Q1 | – | Sell |
-5,704
| Closed | -$31.8K | – | 3323 |
|
|
2015
Q4 | $31.8K | Sell |
5,704
-642
| -10% | -$3.58K | ﹤0.01% | 3094 |
|
|
2015
Q3 | $53.7K | Buy |
6,346
+3,880
| +157% | +$32.8K | ﹤0.01% | 2807 |
|
|
2015
Q2 | $37.3K | Buy |
2,466
+1,785
| +262% | +$27K | ﹤0.01% | 2663 |
|
|
2015
Q1 | $10.9K | Buy |
+681
| New | +$10.9K | ﹤0.01% | 2700 |
|
|
2014
Q4 | – | Sell |
-1,280
| Closed | -$12.9K | – | 3138 |
|
|
2014
Q3 | $12.9K | Buy |
+1,280
| New | +$12.9K | ﹤0.01% | 2970 |
|
|
2014
Q2 | – | Sell |
-45
| Closed | -$620 | – | 3500 |
|
|
2014
Q1 | $620 | Buy |
45
+38
| +543% | +$524 | ﹤0.01% | 2547 |
|
|
2013
Q4 | $134 | Buy |
+7
| New | +$134 | ﹤0.01% | 3490 |
|